Cytokines in innate and adaptive immunity

Reviews in Immunogenetics

Volumn 2, Issue 3, 2000, Pages 359-373

  Banyer, J L ^a   Hamilton, N H R ^a   Ramshaw, I A ^a   Ramsay, A J ^b  

^a Australian National University   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Adaptive immunity; Chemokine; Cytokine; Dendritic cells; Innate immunity

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN GP 39; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; TUMOR NECROSIS FACTOR ALPHA;

ADAPTATION; ANTIMICROBIAL ACTIVITY; B LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; FEEDBACK SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; NONHUMAN; REVIEW; T LYMPHOCYTE;

ANIMALS; AUTOANTIGENS; CELL DIFFERENTIATION; CPG ISLANDS; CYTOKINES; DENDRITIC CELLS; FEEDBACK; GENE EXPRESSION REGULATION; IMMUNITY; IMMUNITY, NATURAL; INFECTION; LYMPHOCYTE SUBSETS; MICE; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; MOLECULAR MIMICRY; RABBITS; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES, HELPER-INDUCER; VIRAL PROTEINS; VIRUSES;

EID: 0034526275     PISSN: 13981714     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (130)

1. Innate immunity: The virtues of a nonclonal system of recognition
2. Innate immune recognition: Mechanisms and pathways
3. Selective suppression of interleukin-12 induction after macrophage receptor ligation
4. The interferon system. A bird's eye view of its biochemistry
5. The serum mannose-binding protein and the macrophage mannose receptor are pattern recognition molecules that link innate and adaptive immunity
6. CpG motifs in bacterial DNA trigger direct B-cell activation
7. Lack of immune stimulation by immobilized CpG-oligodeoxynucleotide
8. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway
9. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation
10. Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA
11. The role of CpG motifs in innate immunity
12. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal
13. Acquisition of lymphokine-producing phenotype by CD4+ T cells
14. Cytokines induce the development of functionally heterogeneous T helper cell subsets
15. Mouse CD1-specific NK1 T cells: Development, specificity, and function
16. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages
17. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
18. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4
19. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling
20. A novel transcription factor, T-bet, directs Th1 lineage commitment
21. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
22. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells
23. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB
24. Purification and characterization of the human interleukin-18 receptor
25. Interleukin-18: A novel cytokine that augments both innate and acquired immunity
26. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-gamma production
27. The role of IL-18 in innate immunity
28. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells
29. Functional diversity of helper T lymphocytes
30. Cytokine transcriptional events during helper T cell subset differentiation
31. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4
32. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells
33. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene
34. Resistance to Leishmania major induced by tolerance to a single antigen
35. Dendritic cells discriminate between yeasts and hyphae of the fungus candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo
36. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells
37. Functional skewing of bone marrow-derived dendritic cells by Th1- or Th2-inducing cytokines
38. Burnet oration: Dendritic cells: Multiple subtypes, multiple origins, multiple functions
39. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity
40. CD8alpha+ and CD8alpha-subclasses of dendritic cells direct the development of distinct T helper cells in vivo
41. Reciprocal control of T helper cell and dendritic cell differentiation
42. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand
43. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses
44. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
45. Purification and characterization of prostaglandin-H E-isomerase, a sigma-class glutathione S-transferase, from Ascaridia galli
46. Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: A mechanism for regulation of CD4+ T-cell subsets
47. Altered cytokine production and accessory cell function after HIV-1 infection
48. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice
49. Mechanism of suppression of cell-mediated immunity by measles virus
50. Dendritic cells directly modulate B cell growth and differentiation
51. DNA immunization in relB-deficient mice discloses a role for dendritic cells in IgM- →IgG1 switch in vivo
52. Dendritic cells, B cells and the regulation of antibody synthesis
53. Human interdigitating dendritic cells induce isotype switching and IL- 13-dependent IgM production in CD40-activated naive B cells
54. Interleukin 13 is a B cell stimulating factor
55. Regulation of B-cell commitment to plasma cells or to memory B cells
56. CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM + IgD + B cell line
57. Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site
58. Dendritic cells at the end of the millennium
59. T helper 1 and T helper 2 cells respond differentially to chemokines
60. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
61. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells
62. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
63. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant
64. Differential CC chemokine-induced enhancement of T helper cell cytokine production
65. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines
66. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice
67. Monocyte chemotactic protein expression during schistosome egg granuloma formation. Sequence of production, localization, contribution, and regulation
68. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens
69. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
70. Selective suppression of IL-12 production by chemoattractants
71. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
72. IL-4 induces functional cell-surface expression of CXCR4 on human T cells
73. Upregulation of integrin alpha6/beta1 and chemokine receptor CCR1 by interleukin-12 promotes the migration of human type 1 helper T cells
74. Localization of Th-cell subsets in inflammation: Differential thresholds for extravasation of Th1 and Th2 cells
75. Acquisition of selectin binding and peripheral homing properties by CD4(+) and CD8(+) T cells
76. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production
77. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells
78. Inhibition by IL-12 and IFN-alpha of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells
79. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines
80. Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells
81. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
82. Activation of naive, memory and effector T cells
83. Macrophage activation by T cells: Cognate and non-cognate signals
84. Lymphocyte responses and cytokines
85. Immunity to viruses
86. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
87. Immune response to chemically modified flagellin. 3. Enhanced cell- mediated immunity during high and low zone antibody tolerance to flagellin
88. Regulation of immunity to parasites by T cells and T cell-derived cytokines
89. Th1 and Th2 subsets: Paradigms lost?
90. T-cell subsets in autoimmunity
91. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity
92. Lymphokine production by human T cells in disease states
93. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
94. Differential regulation of murine T lymphocyte subsets
95. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases
96. OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: Prevention by the OX-22low subset
97. Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines
98. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that in lymphokine secretion pattern and cell surface phenotype
99. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta
100. Immunoregulation by interleukin-12
101. Myb-transformed hematopoietic cells as a model for monocyte differentiation into dendritic cells and macrophages
102. CD47 engagement inhibits cytokine production and maturation of human dendritic cells
103. Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation
104. New lessons for immunology at the host-pathogen interface
105. Modulating chemokines: More lessons from viruses
106. Tumor necrosis factor receptors encoded by poxviruses
107. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence
108. Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes
109. One step ahead of the game: Viral immunomodulatory molecules
110. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway
111. Cytokines and immunity to viral infections
112. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection
113. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity
114. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2
115. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors
116. D40 ligand has potent antiviral activity
117. Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells
118. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines
119. Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo
120. Differentiation of human NK cells into NK1 and NK2 subsets
121. Expression of an adjuvant gene (interferon-gamma) in infectious vaccinia virus recombinants
122. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection
123. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression
124. Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo
125. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma
126. Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo
127. The role of interleukin-6 in mucosal IgA antibody responses in vivo
128. Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus
129. Interleukin-7 enhances cell-mediated immune responses in vivo in an interleukin-2-dependent manner
130. The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo